NCT02230891
Biomarker Guided Therapies in Stage A/B Heart Failure
See it on ClinicalTrials.gov ↗56 people
100%
0 womenmiddle line = equal numbers56 men
- Phase
- PHASE2
- Paid for by
- VA Office of Research and Development
- Finished
- 2020-12-15
- Health conditions
- Hypertension, Diabetes, Cardiovascular Disease
- Who could join
- Anyone
- Ages
- 40 Years – 85 Years
- Average age
- mean 70.1 years
- Age 65+
- 85.7%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 53.6% · Black / African American 46.4% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant women or any woman planning a pregnancy during the study period”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“…tus (controlled: defined as hemoglobin A1c less than 9%) c. Obesity (defined as BMI greater than 30 kg/m2) d. Metabolic syndrome (using the National Cholesterol Education Panel definition) e. Left ventricular hypertrophy (by ECG) f. Coronar…”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Renal insufficiency with estimated Glomerular Filtration Rate (eGFR) less than 60 ml/min”
Study titles and rules are shown in their original English.